Skip to main content

Post Approval Study - Evaluate the Long-Term Safety and Effectiveness of the WEB Device

Active, not recruiting · Not applicable · NCT04839705

Conditions: Wide Neck Bifurcation Intracranial Aneurysms

At a glance

Research payments reported, 2025
$454,339
U.S. investigators named
29
Sites paid
24
Planned or actual enrollment
195

About the trial

Sponsor
Microvention-Terumo, Inc.
Tested
WEB (device)
Dates
Started 2022-08-24; completion 2030-05
Results posted
Not yet

A prospective, multicenter, single arm, interventional study. The target patient population for this study are adult subjects with WNBAs of the anterior and posterior intracranial circulation. The primary effectiveness outcome of the study is adequate intracranial aneurysm occlusion on the 1 year angiogram as adjudicated by a core laboratory.

From ClinicalTrials.gov, last updated 2026-03-27. Full record, eligibility and contacts (opens in a new tab)

Industry funding

Microvention, Inc. reported $454,339 in research payments for this study in 2025 (139 payments).

Products named: Web Aneurysm Embolization System

Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.

U.S. investigators named on this study

Clinicians the company named as principal investigators in its Open Payments reports.

Sites paid to run it

Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.